Literature DB >> 20048019

Suppression of the P50 evoked response and neuregulin 1-induced AKT phosphorylation in first-episode schizophrenia.

Szabolcs Kéri1, Sándor Beniczky, Oguz Kelemen.   

Abstract

OBJECTIVE: Diminished suppression of the P50 auditory evoked potential is a widely used sensory gating phenotype in the molecular genetic studies of schizophrenia. The aim of this study was to explore the relationship between this phenotype and neuregulin 1-related intracellular signaling processes.
METHOD: The P50 evoked potential was recorded in 30 first-episode, never-medicated patients with schizophrenia and in 30 healthy comparison volunteers. Neuregulin 1-induced activation of the phosphoinositide 3'-kinase (PI3K)/protein kinase B (AKT)/glycogen synthase kinase-3beta system was characterized by the measurement of the phosphorylated AKT to total AKT ratio in peripheral B lymphoblasts.
RESULTS: Relative to comparison subjects, patients with first-episode schizophrenia displayed diminished P50 suppression and decreased neuregulin 1-induced AKT phosphorylation. There was a significant relationship between P50 suppression and AKT phosphorylation.
CONCLUSION: Decreased neuregulin 1-induced activation of the PI3K/AKT system is associated with impaired sensory gating in first-episode schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20048019     DOI: 10.1176/appi.ajp.2009.09050723

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  11 in total

1.  Neuregulin 1-induced AKT and ERK phosphorylation in patients with fragile X syndrome (FXS) and intellectual disability associated with obstetric complications.

Authors:  Tamás Kovács; Boglárka Bánsági; Oguz Kelemen; Szabolcs Kéri
Journal:  J Mol Neurosci       Date:  2014-02-23       Impact factor: 3.444

Review 2.  Extracellular matrix proteomics in schizophrenia and Alzheimer's disease.

Authors:  Manveen K Sethi; Joseph Zaia
Journal:  Anal Bioanal Chem       Date:  2016-09-06       Impact factor: 4.142

Review 3.  A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health.

Authors:  Jean-Martin Beaulieu
Journal:  J Psychiatry Neurosci       Date:  2012-01       Impact factor: 6.186

Review 4.  Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia.

Authors:  Daniel C Javitt; Robert Freedman
Journal:  Am J Psychiatry       Date:  2014-11-17       Impact factor: 18.112

5.  Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT/mTOR signaling as a pathological mediator of genetic and environmental programming during development.

Authors:  Kristy R Howell; Amanda J Law
Journal:  Schizophr Res       Date:  2019-09-12       Impact factor: 4.939

6.  Investigation of gene effects and epistatic interactions between Akt1 and neuregulin 1 in the regulation of behavioral phenotypes and social functions in genetic mouse models of schizophrenia.

Authors:  Ching-Hsun Huang; Ju-Chun Pei; Da-Zhong Luo; Ching Chen; Yi-Wen Chen; Wen-Sung Lai
Journal:  Front Behav Neurosci       Date:  2015-01-29       Impact factor: 3.558

7.  Uniting the neurodevelopmental and immunological hypotheses: Neuregulin 1 receptor ErbB and Toll-like receptor activation in first-episode schizophrenia.

Authors:  Szabolcs Kéri; Csilla Szabó; Oguz Kelemen
Journal:  Sci Rep       Date:  2017-06-23       Impact factor: 4.379

8.  Increased expression of receptor phosphotyrosine phosphatase-β/ζ is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypes.

Authors:  N Takahashi; T Sakurai; O Bozdagi-Gunal; N P Dorr; J Moy; L Krug; M Gama-Sosa; G A Elder; R J Koch; R H Walker; P R Hof; K L Davis; J D Buxbaum
Journal:  Transl Psychiatry       Date:  2011-05-10       Impact factor: 6.222

9.  Altered expression of mRNA profiles in blood of early-onset schizophrenia.

Authors:  Yong Xu; Yin Yao Shugart; Guoqiang Wang; Zaohuo Cheng; Chunhui Jin; Kai Zhang; Jun Wang; Hao Yu; Weihua Yue; Fuquan Zhang; Dai Zhang
Journal:  Sci Rep       Date:  2016-01-06       Impact factor: 4.379

Review 10.  BACE1-Dependent Neuregulin-1 Signaling: An Implication for Schizophrenia.

Authors:  Zhengrong Zhang; Jing Huang; Yong Shen; Rena Li
Journal:  Front Mol Neurosci       Date:  2017-09-25       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.